Genes and genetic testing in hereditary ataxias

Genes

Volumn 5, Issue 3, 2014, Pages 586-603

  Sandford, Erin ^a   Burmeister, Margit ^a,b,c  

^a UNIVERSITY OF MICHIGAN   (United States)

^b UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

^c UNIVERSITY OF MICHIGAN HEALTH SYSTEM   (United States)

Author keywords

Ataxia; Genetics; Pathways; Testing

Indexed keywords

EID: 84905571259     PISSN: None     EISSN: 20734425     Source Type: Journal    
DOI: 10.3390/genes5030586     Document Type: Review

References (100)

1. Durr, A. Autosomal dominant cerebellar ataxias: Polyglutamine expansions and beyond. Lancet Neurol. 2010, 9, 885-894.
2. Joo, B.-E.; Lee, C.-N.; Park, K.-W. Prevalence rate and functional status of cerebellar ataxia in Korea. Cerebellum Lond. Engl. 2012, 11, 733-738.
3. Coutinho, P.; Ruano, L.; Loureiro, J.L.; Cruz, V.T.; Barros, J.; Tuna, A.; Barbot, C.; Guimarães, J.; Alonso, I.; Silveira, I. et al. Hereditary ataxia and spastic paraplegia in Portugal: A population-based prevalence study. JAMA Neurol. 2013, 70, 746-755.
4. Koht, J.; Tallaksen, C.M.E. Cerebellar ataxia in the eastern and southern parts of Norway. Acta Neurol. Scand. Suppl. 2007, 187, 76-79.
5. Orr, H.T.; Chung, M.Y.; Banfi, S.; Kwiatkowski, T.J., Jr.; Servadio, A.; Beaudet, A.L.; McCall, A.E.; Duvick, L.A.; Ranum, L.P.; Zoghbi, H.Y. Expansion of an unstable trinucleotide CAG repeat in spinocerebellar ataxia type 1. Nat. Genet. 1993, 4, 221-226.
6. Sanpei, K.; Takano, H.; Igarashi, S.; Sato, T.; Oyake, M.; Sasaki, H.; Wakisaka, A.; Tashiro, K.; Ishida, Y.; Ikeuchi, T. et al. Identification of the spinocerebellar ataxia type 2 gene using a direct identification of repeat expansion and cloning technique, DIRECT. Nat. Genet. 1996, 14, 277-284.
7. Pulst, S.M.; Nechiporuk, A.; Nechiporuk, T.; Gispert, S.; Chen, X.N.; Lopes-Cendes, I.; Pearlman, S.; Starkman, S.; Orozco-Diaz, G.; Lunkes, A. et al. Moderate expansion of a normally biallelic trinucleotide repeat in spinocerebellar ataxia type 2. Nat. Genet. 1996, 14, 269-276.
8. Kawaguchi, Y.; Okamoto, T.; Taniwaki, M.; Aizawa, M.; Inoue, M.; Katayama, S.; Kawakami, H.; Nakamura, S.; Nishimura, M.; Akiguchi, I. CAG expansions in a novel gene for Machado-Joseph disease at chromosome 14q32.1. Nat. Genet. 1994, 8, 221-228.
9. Haberhausen, G.; Damian, M.S.; Leweke, F.; Müller, U. Spinocerebellar ataxia, type 3 (SCA3) is genetically identical to Machado-Joseph disease (MJD). J. Neurol. Sci. 1995, 132, 71-75.
10. Zhuchenko, O.; Bailey, J.; Bonnen, P.; Ashizawa, T.; Stockton, D.W.; Amos, C.; Dobyns, W.B.; Subramony, S.H.; Zoghbi, H.Y.; Lee, C.C. Autosomal dominant cerebellar ataxia (SCA6) associated with small polyglutamine expansions in the alpha 1A-voltage-dependent calcium channel. Nat. Genet. 1997, 15, 62-69.
11. Ng, S.B.; Buckingham, K.J.; Lee, C.; Bigham, A.W.; Tabor, H.K.; Dent, K.M.; Huff, C.D.; Shannon, P.T.; Jabs, E.W.; Nickerson, D.A. et al. Exome sequencing identifies the cause of a mendelian disorder. Nat. Genet. 2010, 42, 30-35.
12. Zanni, G.; Calì, T.; Kalscheuer, V.M.; Ottolini, D.; Barresi, S.; Lebrun, N.; Montecchi-Palazzi, L.; Hu, H.; Chelly, J.; Bertini, E. et al. Mutation of plasma membrane Ca2+ ATPase isoform 3 in a family with X-linked congenital cerebellar ataxia impairs Ca2+ homeostasis. Proc. Natl. Acad. Sci. USA 2012, 109, 14514-14519.
13. Lee, Y.-C.; Durr, A.; Majczenko, K.; Huang, Y.-H.; Liu, Y.-C.; Lien, C.-C.; Tsai, P.-C.; Ichikawa, Y.; Goto, J.; Monin, M.-L. et al. Mutations in KCND3 cause spinocerebellar ataxia type 22. Ann. Neurol. 2012, 72, 859-869.
14. Duarri, A.; Jezierska, J.; Fokkens, M.; Meijer, M.; Schelhaas, H.J.; den Dunnen, W.F.A.; van Dijk, F.; Verschuuren-Bemelmans, C.; Hageman, G.; van de Vlies, P. et al. Mutations in potassium channel kcnd3 cause spinocerebellar ataxia type 19. Ann. Neurol. 2012, 72, 870-880.
15. Winkelmann, J.; Lin, L.; Schormair, B.; Kornum, B.R.; Faraco, J.; Plazzi, G.; Melberg, A.; Cornelio, F.; Urban, A.E.; Pizza, F. et al. Mutations in DNMT1 cause autosomal dominant cerebellar ataxia, deafness and narcolepsy. Hum. Mol. Genet. 2012, 21, 2205-2210.
16. Bilguvar, K.; Tyagi, N.K.; Ozkara, C.; Tuysuz, B.; Bakircioglu, M.; Choi, M.; Delil, S.; Caglayan, A.O.; Baranoski, J.F.; Erturk, O. et al. Recessive loss of function of the neuronal ubiquitin hydrolase UCHL1 leads to early-onset progressive neurodegeneration. Proc. Natl. Acad. Sci. USA 2013, 110, 3489-3494.
17. Sun, Y.; Almomani, R.; Breedveld, G.J.; Santen, G.W.E.; Aten, E.; Lefeber, D.J.; Hoff, J.I.; Brusse, E.; Verheijen, F.W.; Verdijk, R.M. et al. Autosomal recessive spinocerebellar ataxia 7 (SCAR7) is caused by variants in TPP1, the gene involved in classic late-infantile neuronal ceroid lipofuscinosis 2 disease (CLN2 disease). Hum. Mutat. 2013, 34, 706-713.
18. Sailer, A.; Houlden, H. Recent advances in the genetics of cerebellar ataxias. Curr. Neurol. Neurosci. Rep. 2012, 12, 227-236.
19. Lhatoo, S.D.; Rao, D.G.; Kane, N.M.; Ormerod, I.E. Very late onset Friedreich's presenting as spastic tetraparesis without ataxia or neuropathy. Neurology 2001, 56, 1776-1777.
20. Castelnovo, G.; Biolsi, B.; Barbaud, A.; Labauge, P.; Schmitt, M. Isolated spastic paraparesis leading to diagnosis of Friedreich's ataxia. J. Neurol. Neurosurg. Psychiatry 2000, 69, 693.
21. Paulson, H.L. The spinocerebellar ataxias. J. Neuroophthalmol. 2009, 29, 227-237.
22. Baloh, R.W. Episodic ataxias 1 and 2. Handb. Clin. Neurol. 2012, 103, 595-602.
23. Jen, J.C.; Wan, J.; Palos, T.P.; Howard, B.D.; Baloh, R.W. Mutation in the glutamate transporter EAAT1 causes episodic ataxia, hemiplegia, and seizures. Neurology 2005, 65, 529-534.
24. Escayg, A.; de Waard, M.; Lee, D.D.; Bichet, D.; Wolf, P.; Mayer, T.; Johnston, J.; Baloh, R.; Sander, T.; Meisler, M.H. Coding and noncoding variation of the human calcium-channel beta4-subunit gene CACNB4 in patients with idiopathic generalized epilepsy and episodic ataxia. Am. J. Hum. Genet. 2000, 66, 1531-1539.
25. Van de Leemput, J.; Chandran, J.; Knight, M.A.; Holtzclaw, L.A.; Scholz, S.; Cookson, M.R.; Houlden, H.; Gwinn-Hardy, K.; Fung, H.-C.; Lin, X. et al. Deletion at ITPR1 underlies ataxia in mice and spinocerebellar ataxia 15 in humans. PLoS Genet. 2007, 3, e108.
26. Iwaki, A.; Kawano, Y.; Miura, S.; Shibata, H.; Matsuse, D.; Li, W.; Furuya, H.; Ohyagi, Y.; Taniwaki, T.; Kira, J. et al. Heterozygous deletion of ITPR1, but not SUMF1, in spinocerebellar ataxia type 16. J. Med. Genet. 2008, 45, 32-35.
27. Huang, L.; Chardon, J.W.; Carter, M.T.; Friend, K.L.; Dudding, T.E.; Schwartzentruber, J.; Zou, R.; Schofield, P.W.; Douglas, S.; Bulman, D.E. et al. Missense mutations in ITPR1 cause autosomal dominant congenital nonprogressive spinocerebellar ataxia. Orphanet J. Rare Dis. 2012, 7, 67.
28. Cummings, C.J.; Reinstein, E.; Sun, Y.; Antalffy, B.; Jiang, Y.; Ciechanover, A.; Orr, H.T.; Beaudet, A.L.; Zoghbi, H.Y. Mutation of the E6-AP ubiquitin ligase reduces nuclear inclusion frequency while accelerating polyglutamine-induced pathology in SCA1 mice. Neuron 1999, 24, 879-892.
29. Lam, Y.C.; Bowman, A.B.; Jafar-Nejad, P.; Lim, J.; Richman, R.; Fryer, J.D.; Hyun, E.D.; Duvick, L.A.; Orr, H.T.; Botas, J. et al. ATAXIN-1 interacts with the repressor Capicua in its native complex to cause SCA1 neuropathology. Cell 2006, 127, 1335-1347.
30. Suzuki, K.; Zhou, J.; Sato, T.; Takao, K.; Miyagawa, T.; Oyake, M.; Yamada, M.; Takahashi, H.; Takahashi, Y.; Goto, J. et al. DRPLA transgenic mouse substrains carrying single copy of full-length mutant human DRPLA gene with variable sizes of expanded CAG repeats exhibit CAG repeat length- and age-dependent changes in behavioral abnormalities and gene expression profiles. Neurobiol. Dis. 2012, 46, 336-350.
31. Zu, T.; Gibbens, B.; Doty, N.S.; Gomes-Pereira, M.; Huguet, A.; Stone, M.D.; Margolis, J.; Peterson, M.; Markowski, T.W.; Ingram, M.A.C. et al. Non-ATG-initiated translation directed by microsatellite expansions. Proc. Natl. Acad. Sci. USA 2011, 108, 260-265.
32. Cleary, J.D.; Ranum, L.P.W. Repeat-associated non-ATG (RAN) translation in neurological disease. Hum. Mol. Genet. 2013, 22, R45-R51.
33. Todd, P.K.; Oh, S.Y.; Krans, A.; He, F.; Sellier, C.; Frazer, M.; Renoux, A.J.; Chen, K.; Scaglione, K.M.; Basrur, V. et al. CGG repeat-associated translation mediates neurodegeneration in fragile X tremor ataxia syndrome. Neuron 2013, 78, 440-455.
34. Cagnoli, C; Stevanin, G.; Brussino, A.; Barberis, M.; Mancini, C; Margolis, R.L.; Holmes, S.E.; Nobili, M.; Forlani, S.; Padovan, S. et al. Missense mutations in the AFG3L2 proteolytic domain account for ~1.5% of European autosomal dominant cerebellar ataxias. Hum. Mutat. 2010, 31, 1117-1124.
35. Jia, D.; Tang, B.; Chen, Z.; Shi, Y.; Sun, Z.; Zhang, L.; Wang, J.; Xia, K.; Jiang, H. Spinocerebellar ataxia type 28 (SCA28) is an uncommon cause of dominant ataxia among Chinese kindreds. Int. J. Neurosci. 2012,122, 560-562.
36. Knight, M.A.; Kennerson, M.L.; Anney, R.J.; Matsuura, T.; Nicholson, G.A.; Salimi-Tari, P.; Gardner, R.J.M.; Storey, E.; Forrest, S.M. Spinocerebellar ataxia type 15 (sca15) maps to 3p24.2-3pter: Exclusion of the ITPR1 gene, the human orthologue of an ataxic mouse mutant. Neurobiol. Dis. 2003,13, 147-157.
37. Embiruçu, E.K.; Martyn, M.L.; Schlesinger, D.; Kok, F. Autosomal recessive ataxias: 20 types, and counting. Arq. Neuropsiquiatr. 2009, 67, 1143-1156.
38. Fogel, B.L.; Perlman, S. Clinical features and molecular genetics of autosomal recessive cerebellar ataxias. Lancet Neurol. 2007, 6, 245-257.
39. Zamba-Papanicolaou, E.; Koutsou, P.; Daiou, C; Gaglia, E.; Georghiou, A.; Christodoulou, K. High frequency of Friedreich's ataxia carriers in the Paphos district of Cyprus. Acta Myol. 2009, 28, 24-26.
40. Campuzano, V.; Montermini, L.; Moltò, M.D.; Pianese, L.; Cossée, M.; Cavalcanti, F.; Monros, E.; Rodius, F.; Duclos, F.; Monticelli, A. et al. Friedreich's ataxia: Autosomal recessive disease caused by an intronic GAA triplet repeat expansion. Science 1996, 271, 1423-1427.
41. Bidichandani, S.I.; Ashizawa, T.; Patel, P.I. A typical Friedreich ataxia caused by compound heterozygosity for a novel missense mutation and the GAA triplet-repeat expansion. Am. J. Hum. Genet. 1997, 60, 1251-1256.
42. Bidichandani, S.I.; Ashizawa, T.; Patel, P.I. The GAA triplet-repeat expansion in Friedreich ataxia interferes with transcription and may be associated with an unusual DNA structure. Am. J. Hum. Genet. 1998, 62, 111-121.
43. Campuzano, V.; Montermini, L.; Lutz, Y.; Cova, L.; Hindelang, C; Jiralerspong, S.; Trottier, Y.; Kish, S.J.; Faucheux, B.; Trouillas, P. et al. Frataxin is reduced in Friedreich ataxia patients and is associated with mitochondrial membranes. Hum. Mol. Genet. 1997, 6, 1771-1780.
44. Chapdelaine, P.; Coulombe, Z.; Chikh, A.; Gerard, C; Tremblay, J.P. A Potential New Therapeutic Approach for Friedreich Ataxia: Induction of Frataxin Expression with TALE Proteins. Mol. Ther. Nucleic Acids 2013, 2, e119.
45. Le Ber, I.; Bouslam, N; Rivaud-Péchoux, S.; Guimarães, J.; Benomar, A.; Chamayou, C; Goizet, C; Moreira, M.-C; Klur, S.; Yahyaoui, M. et al. Frequency and phenotypic spectrum of ataxia with oculomotor apraxia 2: A clinical and genetic study in 18 patients. Brain J. Neurol. 2004, 127, 759-767.
46. Moreira, M.C.; Barbot, C; Tachi, N; Kozuka, N; Uchida, E.; Gibson, T.; Mendonça, P.; Costa, M.; Barros, J.; Yanagisawa, T. et al. The gene mutated in ataxia-ocular apraxia 1 encodes the new HIT/Zn-finger protein aprataxin. Nat. Genet. 2001, 29, 189-193.
47. Hagerman, R.J.; Leehey, M.; Heinrichs, W.; Tassone, F.; Wilson, R.; Hills, J.; Grigsby, J.; Gage, B.; Hagerman, P.J. Intention tremor, parkinsonism, and generalized brain atrophy in male carriers of fragile X. Neurology 2001, 57, 127-130.
48. Fu, Y.H.; Kuhl, D.P.; Pizzuti, A.; Pieretti, M.; Sutcliffe, J.S.; Richards, S.; Verkerk, A.J.; Holden, J.J.; Fenwick, R.G., Jr.; Warren, S.T. Variation of the CGG repeat at the fragile X site results in genetic instability: resolution of the Sherman paradox. Cell 1991, 67, 1047-1058.
49. Tassone, F.; Iong, K.P.; Tong, T.-H.; Lo, J.; Gane, L.W.; Berry-Kravis, E.; Nguyen, D.; Mu, L.Y.; Laffin, J.; Bailey, D.B. et al. FMR1 CGG allele size and prevalence ascertained through newborn screening in the United States. Genome Med. 2012, 4, 100.
50. Rousseau, F.; Rouillard, P.; Morel, M.L.; Khandjian, E.W.; Morgan, K. Prevalence of carriers of premutation-size alleles of the FMRI gene-And implications for the population genetics of the fragile X syndrome. Am. J. Hum. Genet. 1995, 57, 1006-1018.
51. Dombrowski, C.; Lévesque, S.; Morel, M.L.; Rouillard, P.; Morgan, K.; Rousseau, F. Premutation and intermediate-size FMR1 alleles in 10572 males from the general population: Loss of an AGG interruption is a late event in the generation of fragile X syndrome alleles. Hum. Mol. Genet. 2002, 11, 371-378.
52. Rodriguez-Revenga, L.; Madrigal, I.; Pagonabarraga, J.; Xunclà, M.; Badenas, C.; Kulisevsky, J.; Gomez, B.; Milà, M. Penetrance of FMR1 premutation associated pathologies in fragile X syndrome families. Eur. J. Hum. Genet. EJHG 2009, 17, 1359-1362.
53. Schwartz, C.E.; Dean, J.; Howard-Peebles, P.N.; Bugge, M.; Mikkelsen, M.; Tommerup, N.; Hull, C.; Hagerman, R.; Holden, J.J.; Stevenson, R.E. Obstetrical and gynecological complications in fragile X carriers: a multicenter study. Am. J. Med. Genet. 1994, 51, 400-402.
54. Bertini, E.; des Portes, V.; Zanni, G.; Santorelli, F.; Dionisi-Vici, C.; Vicari, S.; Fariello, G.; Chelly, J. X-linked congenital ataxia: A clinical and genetic study. Am. J. Med. Genet. 2000, 92, 53-56.
55. Holt, I.J.; Harding, A.E.; Petty, R.K.; Morgan-Hughes, J.A. A new mitochondrial disease associated with mitochondrial DNA heteroplasmy. Am. J. Hum. Genet. 1990, 46, 428-433.
56. Synofzik, M.; Srulijes, K.; Godau, J.; Berg, D.; Schöls, L. Characterizing POLG ataxia: Clinics, electrophysiology and imaging. Cerebellum Lond. Engl. 2012, 11, 1002-1011.
57. Faruq, M.; Narang, A.; Kumari, R.; Pandey, R.; Garg, A.; Behari, M.; Dash, D.; Srivastava, A.; Mukerji, M. Novel mutations in typical and atypical genetic loci through exome sequencing in autosomal recessive cerebellar ataxia families. Clin. Genet. 2013, doi:10.1111/cge.12279.
58. Nikali, K.; Suomalainen, A.; Saharinen, J.; Kuokkanen, M.; Spelbrink, J.N.; Lönnqvist, T.; Peltonen, L. Infantile onset spinocerebellar ataxia is caused by recessive mutations in mitochondrial proteins Twinkle and Twinky. Hum. Mol. Genet. 2005, 14, 2981-2990.
59. Hartley, J.N.; Booth, F.A.; del Bigio, M.R.; Mhanni, A.A. Novel Autosomal Recessive c10orf2 Mutations Causing Infantile-Onset Spinocerebellar Ataxia. Case Rep. Pediatr. 2012, 2012, 303096.
60. Wanrooij, S.; Falkenberg, M. The human mitochondrial replication fork in health and disease. Biochim. Biophys. Acta 2010, 1797, 1378-1388.
61. Multiple-System Atrophy Research Collaboration Mutations in COQ2 in familial and sporadic multiple-system atrophy. N. Engl. J. Med. 2013, 369, 233-244.
62. Lim, J.; Hao, T.; Shaw, C.; Patel, A.J.; Szabó, G.; Rual, J.-F.; Fisk, C.J.; Li, N.; Smolyar, A.; Hill, D.E. et al. A protein-protein interaction network for human inherited ataxias and disorders of Purkinje cell degeneration. Cell 2006, 125, 801-814.
63. Conroy, J.; McGettigan, P.; Murphy, R.; Webb, D.; Murphy, S.M.; McCoy, B.; Albertyn, C.; McCreary, D.; McDonagh, C.; Walsh, O. et al. A novel locus for episodic ataxia:UBR4 the likely candidate. Eur. J. Hum. Genet. 2014, 22, 505-510.
64. Lee, J.-H.; Paull, T.T. ATM activation by DNA double-strand breaks through the Mre11-Rad50- Nbs1 complex. Science 2005, 308, 551-554.
65. Regal, J.A.; Festerling, T.A.; Buis, J.M.; Ferguson, D.O. Disease-associated MRE11 mutants impact ATM/ATR DNA damage signaling by distinct mechanisms. Hum. Mol. Genet. 2013, 22, 5146-5159.
66. Suraweera, A.; Becherel, O.J.; Chen, P.; Rundle, N.; Woods, R.; Nakamura, J.; Gatei, M.; Criscuolo, C.; Filla, A.; Chessa, L. et al. Senataxin, defective in ataxia oculomotor apraxia type 2, is involved in the defense against oxidative DNA damage. J. Cell Biol. 2007, 177, 969-979.
67. Takahashi, T.; Tada, M.; Igarashi, S.; Koyama, A.; Date, H.; Yokoseki, A.; Shiga, A.; Yoshida, Y.; Tsuji, S.; Nishizawa, M. et al. Aprataxin, causative gene product for EAOH/AOA1, repairs DNA single-strand breaks with damaged 3'-phosphate and 3'-phosphoglycolate ends. Nucleic Acids Res. 2007, 35, 3797-3809.
68. Zhou, T.; Lee, J.W.; Tatavarthi, H.; Lupski, J.R.; Valerie, K.; Povirk, L.F. Deficiency in 3'-phosphoglycolate processing in human cells with a hereditary mutation in tyrosyl-DNA phosphodiesterase (TDP1). Nucleic Acids Res. 2005, 33, 289-297.
69. El-Khamisy, S.F.; Saifi, G.M.; Weinfeld, M.; Johansson, F.; Helleday, T.; Lupski, J.R.; Caldecott, K.W. Defective DNA single-strand break repair in spinocerebellar ataxia with axonal neuropathy-1. Nature 2005, 434, 108-113.
70. Browne, D.L.; Gancher, S.T.; Nutt, J.G.; Brunt, E.R.; Smith, E.A.; Kramer, P.; Litt, M. Episodic ataxia/myokymia syndrome is associated with point mutations in the human potassium channel gene, KCNA1. Nat. Genet. 1994, 8, 136-140.
71. 2+ channel gene CACNL1A4. Cell 1996, 87, 543-552.
72. Waters, M.F.; Minassian, N.A.; Stevanin, G.; Figueroa, K.P.; Bannister, J.P.A.; Nolte, D.; Mock, A.F.; Evidente, V.G.H.; Fee, D.B.; Müller, U. et al. Mutations in voltage-gated potassium channel KCNC3 cause degenerative and developmental central nervous system phenotypes. Nat. Genet. 2006, 38, 447-451.
73. 2+ from a nonmitochondrial intracellular store in pancreatic acinar cells by inositol-1,4,5-trisphosphate. Nature 1983, 306, 67-69.
74. Berridge, M.J. Inositol trisphosphate and calcium signalling mechanisms. Biochim. Biophys. Acta 2009, 1793, 933-940.
75. Valdmanis, P.N.; Dupré, N.; Lachance, M.; Stochmanski, S.J.; Belzil, V.V.; Dion, P.A.; Thiffault, I.; Brais, B.; Weston, L.; Saint-Amant, L. et al. A mutation in the RNF170 gene causes autosomal dominant sensory ataxia. Brain J. Neurol. 2011, 134, 602-607.
76. Lu, J.P.; Wang, Y.; Sliter, D.A.; Pearce, M.M.P.; Wojcikiewicz, R.J.H. RNF170 protein, an endoplasmic reticulum membrane ubiquitin ligase, mediates inositol 1,4,5-trisphosphate receptor ubiquitination and degradation. J. Biol. Chem. 2011, 286, 24426-24433.
77. Durcan, T.M.; Kontogiannea, M.; Thorarinsdottir, T.; Fallon, L.; Williams, A.J.; Djarmati, A.; Fantaneanu, T.; Paulson, H.L.; Fon, E.A. The Machado-Joseph disease-associated mutant form of ataxin-3 regulates parkin ubiquitination and stability. Hum. Mol. Genet. 2011, 20, 141-154.
78. Margolin, D.H.; Kousi, M.; Chan, Y.-M.; Lim, E.T.; Schmahmann, J.D.; Hadjivassiliou, M.; Hall, J.E.; Adam, I.; Dwyer, A.; Plummer, L. et al. Ataxia, dementia, and hypogonadotropism caused by disordered ubiquitination. N. Engl. J. Med. 2013, 368, 1992-2003.
79. Shi, C.-H.; Schisler, J.C.; Rubel, C.E.; Tan, S.; Song, B.; McDonough, H.; Xu, L.; Portbury, A.L.; Mao, C.-Y.; True, C. et al. Ataxia and hypogonadism caused by the loss of ubiquitin ligase activity of the U box protein CHIP. Hum. Mol. Genet. 2014, 23, 1013-1024.
80. Lee, T.I.; Young, R.A. Transcriptional regulation and its misregulation in disease. Cell 2013, 152, 1237-1251.
81. Serra, H.G.; Duvick, L.; Zu, T.; Carlson, K.; Stevens, S.; Jorgensen, N.; Lysholm, A.; Burright, E.; Zoghbi, H.Y.; Clark, H.B. et al. RORalpha-mediated Purkinje cell development determines disease severity in adult SCA1 mice. Cell 2006, 127, 697-708.
82. Ju, H.; Kokubu, H.; Todd, T.W.; Kahle, J.J.; Kim, S.; Richman, R.; Chirala, K.; Orr, H.T.; Zoghbi, H.Y.; Lim, J. Polyglutamine disease toxicity is regulated by Nemo-like kinase in spinocerebellar ataxia type 1. J. Neurosci. 2013, 33, 9328-9336.
83. Konno, A.; Shuvaev, A.N.; Miyake, N.; Miyake, K.; Iizuka, A.; Matsuura, S.; Huda, F.; Nakamura, K.; Yanagi, S.; Shimada, T. et al. Mutant Ataxin-3 with an Abnormally Expanded Polyglutamine Chain Disrupts Dendritic Development and Metabotropic Glutamate Receptor Signaling in Mouse Cerebellar Purkinje Cells. Cerebellum 2013, 13, 29-41.
84. Dussault, I.; Fawcett, D.; Matthyssen, A.; Bader, J.A.; Giguère, V. Orphan nuclear receptor ROR alpha-deficient mice display the cerebellar defects of staggerer. Mech. Dev. 1998, 70, 147-153.
85. Suraweera, A.; Lim, Y.; Woods, R.; Birrell, G.W.; Nasim, T.; Becherel, O.J.; Lavin, M.F. Functional role for senataxin, defective in ataxia oculomotor apraxia type 2, in transcriptional regulation. Hum. Mol. Genet. 2009, 18, 3384-3396.
86. Cruz-Mariño, T.; Velázquez-Pérez, L.; González-Zaldivar, Y.; Aguilera-Rodríguez, R.; Velázquez-Santos, M.; Vázquez-Mojena, Y.; Estupiñán-Rodríguez, A.; Reynaldo-Armiñán, R.; Almaguer-Mederos, L.E.; Laffita-Mesa, J.M. et al. Couples at risk for spinocerebellar ataxia type 2: the Cuban prenatal diagnosis experience. J. Community Genet. 2013, 4, 451-460.
87. Erez, A.; Plunkett, K.; Sutton, V.R.; McGuire, A.L. The right to ignore genetic status of late onset genetic disease in the genomic era; Prenatal testing for Huntington disease as a paradigm. Am. J. Med. Genet. A 2010, 152A, 1774-1780.
88. Archibald, A.D.; Hickerton, C.L.; Jaques, A.M.; Wake, S.; Cohen, J.; Metcalfe, S.A. "It's about having the choice": Stakeholder perceptions of population-based genetic carrier screening for fragile X syndrome. Am. J. Med. Genet. A 2013, 161A, 48-58.
89. Andersson, P.L.; Juth, N.; Petersén, Å.; Graff, C.; Edberg, A.-K. Ethical aspects of undergoing a predictive genetic testing for Huntington's disease. Nurs. Ethics 2013, 20, 189-199.
90. Tanaka, K.; Sekijima, Y.; Yoshida, K.; Tamai, M.; Kosho, T.; Sakurai, A.; Wakui, K.; Ikeda, S.; Fukushima, Y. Follow-up nationwide survey on predictive genetic testing for late-onset hereditary neurological diseases in Japan. J. Hum. Genet. 2013, 58, 560-563.
91. Doi, H.; Ohba, C.; Tsurusaki, Y.; Miyatake, S.; Miyake, N.; Saitsu, H.; Kawamoto, Y.; Yoshida, T.; Koyano, S.; Suzuki, Y. et al. Identification of a novel homozygous SPG7 mutation in a Japanese patient with spastic ataxia: making an efficient diagnosis using exome sequencing for autosomal recessive cerebellar ataxia and spastic paraplegia. Intern. Med. Tokyo Jpn. 2013, 52, 1629-1633.
92. UW Laboratory Medicine Clinical Test Information. Available online: http://web.labmed. washington.edu/tests/genetics/SCAPN/ (accessed on 18 April 2014).
93. Athena Diagnostics: Test Catalog. Available online: http://www.athenadiagnostics.com/ content/test-catalog/ (accessed on 18 April 2014).
94. Yang, Y.; Muzny, D.M.; Reid, J.G.; Bainbridge, M.N.; Willis, A.; Ward, P.A.; Braxton, A.; Beuten, J.; Xia, F.; Niu, Z. et al. Clinical whole-exome sequencing for the diagnosis of mendelian disorders. N. Engl. J. Med. 2013, 369, 1502-1511.
95. Hammer, M.B.; Eleuch-Fayache, G.; Gibbs, J.R.; Arepalli, S.K.; Chong, S.B.; Sassi, C.; Bouhlal, Y.; Hentati, F.; Amouri, R.; Singleton, A.B. Exome sequencing: an efficient diagnostic tool for complex neurodegenerative disorders. Eur. J. Neurol. Off. J. Eur. Fed. Neurol. Soc. 2013, 20, 486-492.
96. Sawyer, S.L.; Schwartzentruber, J.; Beaulieu, C.L.; Dyment, D.; Smith, A.; Warman Chardon, J.; Yoon, G.; Rouleau, G.A.; Suchowersky, O.; Siu, V. et al. Exome sequencing as a diagnostic tool for pediatric-onset ataxia. Hum. Mutat. 2014, 35, 45-49.
97. Németh, A.H.; Kwasniewska, A.C.; Lise, S.; Parolin Schnekenberg, R.; Becker, E.B.E.; Bera, K.D.; Shanks, M.E.; Gregory, L.; Buck, D.; Zameel Cader, M. et al. Next generation sequencing for molecular diagnosis of neurological disorders using ataxias as a model. Brain J. Neurol. 2013, 136, 3106-3118.
98. Ohba, C.; Osaka, H.; Iai, M.; Yamashita, S.; Suzuki, Y.; Aida, N.; Shimozawa, N.; Takamura, A.; Doi, H.; Tomita-Katsumoto, A. et al. Diagnostic utility of whole exome sequencing in patients showing cerebellar and/or vermis atrophy in childhood. Neurogenetics 2013, 14, 225-232.
99. Baylor College of Medicine: Medical Genetics Laboratories. Available online: https://www.bcm.edu/ research/medical-genetics-labs/test_detail.cfm?testcode=1500/ (accessed on 18 April 2014).
100. The University of Chicago: Ataxia Exome Panel. Available online: http://dnatesting.uchicago.edu/ tests/676/ (accessed on 18 April 2014).